Therapeutic Zinc in Childhood Pneumonia
Efficacy of Zinc as Adjuvant Therapy in the Treatment of Severe Pneumonia in Nepalese Children at the Kanti Children's Hospital
Sponsor: All India Institute of Medical Sciences
A PHASE2/PHASE3 clinical study on Pneumonia, this trial is completed. The trial is conducted by All India Institute of Medical Sciences and has accumulated 7 data snapshots since 2006. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Change History
7 versions recorded-
Jul 2025 — Present [monthly]
Completed PHASE2/PHASE3
-
Sep 2024 — Jul 2025 [monthly]
Completed PHASE2/PHASE3
-
Jul 2024 — Sep 2024 [monthly]
Completed PHASE2/PHASE3
Phase: PHASE2_PHASE3 → PHASE2/PHASE3
-
Jan 2021 — Jul 2024 [monthly]
Completed PHASE2_PHASE3
-
Jun 2018 — Jan 2021 [monthly]
Completed PHASE2_PHASE3
▶ Show 2 earlier versions
-
Feb 2017 — Jun 2018 [monthly]
Completed PHASE2_PHASE3
-
Jan 2017 — Feb 2017 [monthly]
Completed PHASE2_PHASE3
First recorded
Jan 2006
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- All India Institute of Medical Sciences
- Centre For International Health
- Institut de Recherche pour le Developpement
- Society for Applied Studies
- Statens Serum Institut
- Tribhuvan University, Nepal
For direct contact, visit the study record on ClinicalTrials.gov .
Study Locations
- • Kathmandu, Nepal